Patent US4839296A successfully refreshed from Google Patents.
US4839296A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Blood plasma test method
Assignee: CHEM-ELEC Inc PO BOX 372 NORTH WEBSTER INDIANA 46555 A CORP OF INDIANA
•
Filing: 1985-10-18
•
Granted: 1989-06-13
•
Expires: 2005-10-18
Abstract
Abstract Single or multiple blood plasma component concentrations are measured by a disposable stick having one or more blood plasma component reactive areas covered by a semipermeable membrane which is permeable by blood plasma or serum components and inpermeable by blood cellular and particulate matter. A second overlap may be superposed with the semipermeable membrane over the reactive areas to receive a blood sample and meter and distribute that sample uniformly to the semipermeable membrane which in turn passes the plasma components uniformly to the reactive areas. The overlays are subsequently separable from the reactive area to remove the cellular components and particulate matter and expose the reactive areas for inspection by, for example, color comparison to standardized charts.
Inventors
- 👤 Paul R. Kennedy
- 👤 Ernest C. Adams
- 👤 William E. Woenker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 17:06
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; C12Q1/58; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5002; G01N33/52; C12Q2326/00; C12Q2326/10; C12Q2326/12; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/255
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
147 words
A process of testing whole blood to determine the concentration of certain plasma components thereof comprising the steps of: treating an expanded hydrophobic polytetrafluoroethylene containing semipermeable membrane with a surfactant to make the membrane hydrophilic and capable of passing plasma components of whole blood while retaining cellular and particulate components of whole blood, the semipermeable membrane having pores which are made hydrophilic by treatment with the surfactant; superposing the semipermeable membrane over a blood plasma component reactive area; subjecting the semipermeable membrane to a whole blood sample so that plasma components of the sample pass through the membrane and onto the reactive area while cellular and particulate blood components are blocked by the membrane; separating the polytetrafluoroethylene containing membrane from the reactive area; and determining the concentration of plasma components in the sample by measuring the extent of any plasma component induced change in the reactive area.
Claim 2
Dependent Claim
147 words
A process of testing whole blood to determine the concentration of certain plasma components thereof comprising the steps of: treating an expanded hydrophobic polytetrafluoroethylene containing semipermeable membrane with a surfactant to make the membrane hydrophilic and capable of passing plasma components of whole blood while retaining cellular and particulate components of whole blood, the semipermeable membrane having pores which are made hydrophilic by treatment with the surfactant; superposing the semipermeable membrane over a blood plasma component reactive area; subjecting the semipermeable membrane to a whole blood sample so that plasma components of the sample pass through the membrane and onto the reactive area while cellular and particulate blood components are blocked by the membrane; separating the polytetrafluoroethylene containing membrane from the reactive area; and determining the concentration of plasma components in the sample by measuring the extent of any plasma component induced change in the reactive area.
Claim 3
Dependent Claim
19 words
The process of claim 1 wherein the step of measuring includes observing a color change in the reactive area.
Claim 4
Dependent Claim
40 words
The process of claim 1 wherein the step of measuring includes at least one of: visual comparison of the color of the reactive area with a calibrated color chart; color comparison employing a reflectometer; and color comparison employing a densitometer.
Claim 5
Dependent Claim
19 words
The process of claim 1 wherein the semipermeable membrane has pores ranging in size from 0.2 to 15 microns.
Claim 6
Dependent Claim
28 words
The process of claim 1 wherein the surfactant is an anionic surfactant selected from the group consisting of lauryl sulphate, sodium tetradecyl sulfate, and aliphatic polyethyleneoxy phosphate ester.
Claim 7
Dependent Claim
17 words
The process of claim 1 wherein the surfactant is para diisobutyl phenoxy ethoxy ethyl dimethyl benzylammonium chloride.
Claim 8
Dependent Claim
14 words
The process of claim 1 wherein the surfactant is poly(3-8)tetrafluoroethylene isopropylacetate dimethylammonium acetic acid.
Claim 9
Dependent Claim
54 words
The process of claim 1 wherein the surfactant is a nonionic surfactant selected from the group consisting of alkyl polyether alcohol, polysorbate 80, polyoxyethylene 23-lauryl ether, nonyl phenoxy poly(9)ethyleneoxy ethanol, nonyl phenoxy poly(10-11)ethyleneoxy ethanol, decyloxy poly(6)ethyleneoxy ethanol, modified linear aliphatic polyether, nonyl phenoxy poly(9)ethyleneoxy ethanol, isooctyl phenyl poly(9-10)ethoxy ethanol, and isooctyl phenyl poly(5)ethoxy ethanol.
Claim 10
Dependent Claim
54 words
The process of claim 1 including the additional step of covering the semipermeable membrane with an absorbent overlay prior to the step of subjecting, the absorbent overlay functioning during the subsequent subjecting step to distribute the same over the semipermeable membrane and therefore also distribute plasma components of the sample over the reactive area.
Claim 11
Dependent Claim
20 words
The process of claim 9 wherein the absorbent overlay is treated with a surfactant prior to the step of subjecting.
References Cited (Backward Citations)
US3092465A
Cited
US3368872A
Cited
US3992158A
Cited
US3983005A
Cited
US4066403A
Cited
US4248924A
Cited
US4144306A
Cited
US4223089A
Cited
US4292272A
Cited
US4613441A
Cited
US4477575A
Cited
US4477575B1
Cited
US4476222A
Cited
US4501785A
Cited
US4501793A
Cited
US4525374A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-12 | 1992-12-12 | 1993-06-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-12 | 1996-12-12 | 1997-06-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-12 | 2000-12-12 | 2001-06-13 | $7700.00 | Window Closed / Lapsed |